v3.22.2.2
Note 3 - Merger with Old Cytocom - Purchase Price (Details) - Cleveland BioLabs, Inc. [Member]
Jul. 27, 2021
USD ($)
$ / shares
shares
Number of shares of the combined company owned by Cleveland BioLabs, Inc. stockholders (in shares) | shares 15,478,945 [1]
Multiplied by the price per share of Cleveland BioLabs, Inc. common stock (in dollars per share) | $ / shares $ 4.99 [2]
Total purchase price | $ $ 77,239,936
[1] Represents the number of shares of common stock of the combined company that Cleveland BioLabs, Inc. stockholders owned as of the closing of the Merger pursuant to the Merger Agreement.
[2] The fair value of Cleveland BioLabs, Inc. common stock used in determining the purchase price was $4.99.